Polymorphisms in chloroquine resistance-associated genes in Plasmodium vivax in Ethiopia

BACKGROUND: Evidence for decreasing chloroquine (CQ) efficacy against Plasmodium vivax has been reported from many endemic countries in the world. In Ethiopia, P. vivax accounts for 40% of all malaria cases and CQ is the first-line drug for vivax malaria. Mutations in multidrug resistance 1 (pvmdr-1...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Malar J
Auteurs principaux: Golassa, Lemu, Erko, Berhanu, Baliraine, Frederick N, Aseffa, Abraham, Swedberg, Göte
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2015
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4404130/
https://ncbi.nlm.nih.gov/pubmed/25889237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0625-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires